Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline for Smoking Cessation in Pancreatitis: An Open-Label Trial

NCT07874841 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07874841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07874841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline for Smoking Cessation in Pancreatitis: An Open-Label Trial
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 13, 2026
Completion date
November 1, 2029
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis (ap), chronic pancreatitis, pancreatitis, recurrent acute pancreatitis